MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/s2352-3026(23)00265-x

Медицинская библиотека · The Lancet. Haematology · 2023

Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.

Gurnari Carmelo, Robin Marie, Godley Lucy A, Drozd-Sokołowska Joanna, Włodarski Marcin W, Raj Kavita, Onida Francesco, Worel Nina, Ciceri Fabio, Carbacioglu Selim, Kenyon Michelle, Aljurf Mahmoud, Bonfim Carmem, Makishima Hideki, Niemeyer Charlotte, Fenaux Pierre, Zebisch Armin, Hamad Nada, Chalandon Yves, Hellström-Lindberg Eva, Voso Maria Teresa, Mecucci Cristina, Duarte Fernando Barroso, Sebert Marie, Sicre de Fontbrune Flore, Soulier Jean, Shimamura Akiko, Lindsley R Coleman, Maciejewski Jarosław P, Calado Rodrigo T, Yakoub-Agha Ibrahim, McLornan Donal P

СтатьяОбзорConsensus StatementПеревод в очереди

Аннотация

The recent application of whole exome or whole genome sequencing unveiled a plethora of germline variants predisposing to myeloid disorders, particularly myelodysplastic neoplasms. The presence of such variants in patients with myelodysplastic syndromes has important clinical repercussions for haematopoietic stem-cell transplantation, from donor selection and conditioning regimen to graft-versus-host disease prophylaxis and genetic counselling for relatives. No international guidelines exist to harmonise management approaches to this particular clinical scenario. Moreover, the application of germline testing, and how this informs clinical decisions, differs according to the expertise of individual clinical practices and according to different countries, health-care systems, and legislations. Leveraging the global span of the European Society for Blood and Marrow Transplantation (EBMT) network, we took a snapshot of the current European situation on these matters by disseminating an electronic survey to EBMT centres experienced in myelodysplastic syndromes transplantation. An international group of haematologists, transplantation physicians, paediatricians, nurses, and experts in molecular biology and constitutional genetics with experience in myelodysplastic syndromes contributed to this Position Paper. The panel met during multiple online meetings to discuss the results of the EBMT survey and to establish suggested harmonised guidelines for such clinical situations, which are presented here.

Для цитирования: Gurnari Carmelo, Robin Marie, Godley Lucy A, Drozd-Sokołowska Joanna, Włodarski Marcin W, Raj Kavita, Onida Francesco, Worel Nina, Ciceri Fabio, Carbacioglu Selim, Kenyon Michelle, Aljurf Mahmoud, Bonfim Carmem, Makishima Hideki, Niemeyer Charlotte, Fenaux Pierre, Zebisch Armin, Hamad Nada, Chalandon Yves, Hellström-Lindberg Eva, Voso Maria Teresa, Mecucci Cristina, Duarte Fernando Barroso, Sebert Marie, Sicre de Fontbrune Flore, Soulier Jean, Shimamura Akiko, Lindsley R Coleman, Maciejewski Jarosław P, Calado Rodrigo T, Yakoub-Agha Ibrahim, McLornan Donal P. Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.. The Lancet. Haematology. 2023. DOI: 10.1016/s2352-3026(23)00265-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.